central serous retinopathy

(redirected from Central serous chorioretinopathy)
Also found in: Acronyms.


any noninflammatory disease of the retina.
central serous retinopathy a usually self-limiting condition marked by acute localized detachment of the neural retina or retinal pigment epithelium in the region of the macula, with hypermetropia.
circinate retinopathy a condition marked by a circle of white spots enclosing the macular area, leading to complete foveal blindness.
diabetic retinopathy retinal manifestations of diabetes mellitus, including microaneurysms and punctate exudates. There are two major forms of diabetic retinopathy, nonproliferative and proliferative. The nonproliferative form is characterized by dilation of the retinal veins and microaneurysms which may leak blood cells and/or plasma, causing internal hemorrhaging or edema in the retina. Edema in peripheral areas of the retina goes unnoticed by the patient and may go untreated, whereas edema occurring in the central retina (macula) causes noticeably decreased vision and is the primary cause of vision loss in nonproliferative disease. (See Atlas 4, Part D.) Treatment by local laser photocoagulation is aimed at sealing shut the breaks in the blood vessels and preventing additional leakage of fluid into the area. Early diagnosis and treatment are essential in this disease to enhance a final visual outcome of stabilization and prevention of further loss of vision.

In proliferative diabetic retinopathy new blood vessels form near the optic disk, break through the inner membranous lining, and grow on the vitreous chamber and elsewhere in the retina and may rupture, causing gross vitreous hemorrhage. Additionally, fibrous tissue is generated secondary to the new blood vessel formation, and both the fibrous tissue and the new blood vessels become firmly attached to the posterior vitreous face. As the vitreous humor moves, the blood vessels and fibrous tissue cause tractional pulling on the retina and may result in separation or detachment of areas of retina. Panretinal laser photocoagulation is the definitive therapy. The study of early treatment for diabetic retinopathy proved the efficacy of this procedure in causing regression of the new blood vessels and prevention of vitreous hemorrhage and tractional retinal detachments, the two major causes of vision loss from this form of the disease.
exudative retinopathy a condition marked by masses of white or yellowish exudate in the posterior part of the fundus oculi, with deposits of cholestrin and blood debris from retinal hemorrhage, and leading to destruction of the macula and blindness.
hemorrhagic retinopathy retinopathy marked by profuse hemorrhaging in the retina, occurring in diabetes, occlusion of the central vein, and hypertension.
hypertensive retinopathy that associated with essential hypertension; changes may include irregular narrowing of the retinal arterioles, hemorrhages in the nerve fiber layers and the outer plexiform layer, exudates and cotton-wool patches, arteriosclerotic changes, and, in malignant hypertension, papilledema. (See also Atlas 4, Part C.)
leukemic retinopathy a condition occurring in leukemia, with paleness of the fundus resulting from infiltration of the retina and choroid with leukocytes, and swelling of the disk with blurring of its margin.
retinopathy of prematurity a disease of the developing retinal vasculature of the premature newborn. The incidence correlates with degree of prematurity; that is, the more premature the infant is, the greater the possibility of this condition occurring. The cause is vasoconstriction of retinal capillaries due to the presence of very high concentrations of oxygen in these blood vessels, which produces an overgrowth of retinal blood vessels. The vascular proliferation and exudation of blood and serum detaches the retina and produces scarring and inevitable blindness. To prevent retinopathy of prematurity it is recommended that oxygen be administered to premature newborns in as low a concentration and for as short a time as feasible. Careful monitoring of the newborn and evaluation of oxygen tension level are essential because no totally safe dosage of oxygen that will prevent the retinal changes has been found. Called also retrolental fibroplasia.
proliferative retinopathy the proliferative type of diabetic retinopathy.

cen·tral se·rous cho·roi·dop·a·thy

an idiopathic sensory retinal detachment in the macula; more common in males.

central serous retinopathy

Abbreviation: CSR
Serous detachment under the macula due to leakage of fluid from the choriocapillaris into the subretinal space between the retina and retinal pigment epithelium. It occurs most often in men aged 20 to 40, typically involves one eye, and often resolves spontaneously.
See also: retinopathy

central serous retinopathy; 

vision; visual acuity
References in periodicals archive ?
Central serous chorioretinopathy (CSCR) is characterised by the accumulation of subretinal fluid at the posterior pole of the fundus, ultimately causing retinal detachment.
Central serous chorioretinopathy (CSCR) is an idiopathic chorioretinal disease which causes serous detachment in the neurosensory retina, which may also be accompanied by pigment epithelium detachment.
OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography.
Central Serous Chorioretinopathy associated with pregnancy usually spontaneously resolves with minimal consequences without intervention after delivery of the baby (18).
Conclusion: Central serous chorioretinopathy in the study sample was associated with pigment epithelial detachment, bilateral involvement, and presence of systemic diseases.
Chronic high blood pressure or blood pressure jumps duringsuccessive incidents of stress may weaken capillaries near the retina and increase the likelihood of developing central serous chorioretinopathy, suggest the researchers.
Sub-internal limiting membrane cavity following Valsalva retinopathy simulating central serous chorioretinopathy J Ophthalmic Vis Res.
Caption: Figure 4 SS-OCT image of central serous chorioretinopathy.
Conclusion: Half adult dose rifampicin (300mg) is effective and safe in treatment of central serous chorioretinopathy without causing any systemic imbalance.
26 January 2012 - IRIDEX Corporation (NASDAQ:IRIX), a US-based provider of therapeutic based laser systems, unveiled on Wednesday positive results of a clinical trial of its MicroPulse laser therapy examining its tissue-sparing effectiveness with patients suffering from central serous chorioretinopathy (CSC).
INTRODUCTION: Central serous chorioretinopathy is a chorioretinal disorder, incompletely understood, with systemic associations, multifactorial etiology and complex pathogenesis.

Full browser ?